Home|Journals|Articles by Year|Audio Abstracts

Original Research

Characterıstıcs of Ethambutol optıc neuropathy on tuberculosıs treatment ın Sanglah Hospıtal Denpasar

Ida Ayu Sri Indrayani,I Gusti Agung Gede Ariswanda,DPG Purwa Samatra,AAA Masputra,I Putu Eka Widyadharma.

Cited by 0 Articles

Background: Enforcement of ethambutol toxic optic neuropathy diagnosis uses visual examination, (relative afferent pupillary defect) RAPD, contrast sensitivity, color vision, visual field, and patient complaints that are subjective so that an objective investigation is needed using visual evoked potential (VEP). Method: This study was a cross-sectional descriptive study in 30 pulmonary tuberculosis patients and were therefore referred to the pulmonology clinic of Public General Sanglah Hospital, Denpasar, from May 13 to August 13, 2018, based on medical record data. This study aims to determine the characteristics of patients with ethambutol toxic optic neuropathy at the pulmonology clinic of Public General Sanglah Hospital Denpasar. Results: We reported 30 patients, 19 were male and 11 female, mean age 33 years, visual acuity disorder and red-green dyschromatopsia seven people, and optic nerve lesions five people.. Impaired visual acuity, color dyschromatopsia, and VEP abnormalities found in patients with ethambutol treatment for five months. Conclusions: Impaired visual acuity, color dyschromatopsia, and optic nerve (ON) lesion obtained in the treatment of the age of five months.

Key words: VEP, neuropathy optics, ethambutol, tuberculosis

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.